RU2019126238A3 - - Google Patents

Download PDF

Info

Publication number
RU2019126238A3
RU2019126238A3 RU2019126238A RU2019126238A RU2019126238A3 RU 2019126238 A3 RU2019126238 A3 RU 2019126238A3 RU 2019126238 A RU2019126238 A RU 2019126238A RU 2019126238 A RU2019126238 A RU 2019126238A RU 2019126238 A3 RU2019126238 A3 RU 2019126238A3
Authority
RU
Russia
Application number
RU2019126238A
Other versions
RU2757771C2 (ru
RU2019126238A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2019126238A publication Critical patent/RU2019126238A/ru
Publication of RU2019126238A3 publication Critical patent/RU2019126238A3/ru
Application granted granted Critical
Publication of RU2757771C2 publication Critical patent/RU2757771C2/ru

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4727Calcium binding proteins, e.g. calmodulin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/105Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/108Osteoporosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Electrotherapy Devices (AREA)
  • Prostheses (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
RU2019126238A 2017-02-07 2018-02-07 Биомаркеры для диагностики связанного с имплантом риска повторной операции с имплантом из-за асептического расшатывания RU2757771C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20170185 2017-02-07
NO20170185 2017-02-07
PCT/EP2018/053044 WO2018146129A1 (en) 2017-02-07 2018-02-07 Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening

Publications (3)

Publication Number Publication Date
RU2019126238A RU2019126238A (ru) 2021-03-09
RU2019126238A3 true RU2019126238A3 (ru) 2021-05-28
RU2757771C2 RU2757771C2 (ru) 2021-10-21

Family

ID=61526773

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019126238A RU2757771C2 (ru) 2017-02-07 2018-02-07 Биомаркеры для диагностики связанного с имплантом риска повторной операции с имплантом из-за асептического расшатывания

Country Status (13)

Country Link
US (3) US11402389B2 (ru)
EP (1) EP3580571B1 (ru)
JP (1) JP7108638B2 (ru)
KR (1) KR102457657B1 (ru)
CN (1) CN110446929A (ru)
AU (1) AU2018217872B2 (ru)
BR (1) BR112019016182A8 (ru)
CA (1) CA3052720A1 (ru)
ES (1) ES2948232T3 (ru)
IL (1) IL268377B2 (ru)
PL (1) PL3580571T3 (ru)
RU (1) RU2757771C2 (ru)
WO (1) WO2018146129A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2948232T3 (es) * 2017-02-07 2023-09-06 Lyfstone B V Biomarcadores para diagnosticar el riesgo de revisión del implante relacionado con el implante debido a un aflojamiento aséptico

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318184A1 (de) 1983-05-19 1984-11-22 Boehringer Mannheim Gmbh, 6800 Mannheim Traeger zur beschichtung mit immunologisch aktivem material
CH685959A5 (de) * 1992-08-24 1995-11-15 Biomedicals Ag Diagnostische Testpackung zur Bestimmung von Proteinen.
US5776348A (en) * 1995-02-07 1998-07-07 Massachusetts Institute Of Technology Mineral precipitation system and method for inhibiting mineral precipitate formation
DE60327075D1 (de) 2002-07-05 2009-05-20 Univ Laval Der entzündungsreaktionen
US20040180383A1 (en) * 2002-11-25 2004-09-16 Boynton Erin Lynn Methods for predicting the predisposition of an individual to total joint replacement failure
GB0229747D0 (en) * 2002-12-20 2003-01-29 Axis Shield Asa Assay
US20060105419A1 (en) * 2004-08-16 2006-05-18 Biosite, Inc. Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions
WO2006047820A1 (en) 2004-11-01 2006-05-11 Newsouth Innovations Pty Limited Use of calgranulin a and b in the promotion and inhibition of mineralized tissue formation
RU2305285C2 (ru) * 2005-06-01 2007-08-27 Государственное образовательное учреждение дополнительного профессионального образования Министерства здравоохранения Российской Федерации Новокузнецкий государственный институт усовершенствования врачей Способ выбора лабораторных методов для прогнозирования развития посттравматических гнойно-воспалительных осложнений в ортопедии и травматологии
GB0705400D0 (en) 2007-03-21 2007-05-02 Univ Aberdeen Therapeutic compounds andm their use
WO2013132347A2 (en) 2012-03-06 2013-09-12 Calpro As Improved elisa immunoassay for calprotectin
WO2015059168A1 (en) * 2013-10-22 2015-04-30 Novimmune S.A. Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of tlr4 ligands and other biomarkers
WO2015061534A1 (en) * 2013-10-25 2015-04-30 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Methods for diagnosing, screening, identifying, monitoring, and treating adverse local tissue reactions in orthopedic implants
JP2016031306A (ja) * 2014-07-29 2016-03-07 株式会社松風 歯周病の検査方法および検査診断キット
EP3331572A4 (en) * 2015-08-04 2019-05-01 CD Diagnostics, Inc. METHOD FOR DETECTING UNWANTED LOCAL TISSUE ACTION NEKROSIS
ES2948232T3 (es) * 2017-02-07 2023-09-06 Lyfstone B V Biomarcadores para diagnosticar el riesgo de revisión del implante relacionado con el implante debido a un aflojamiento aséptico

Also Published As

Publication number Publication date
US20230081885A1 (en) 2023-03-16
JP2020507783A (ja) 2020-03-12
RU2757771C2 (ru) 2021-10-21
AU2018217872B2 (en) 2021-05-20
KR102457657B1 (ko) 2022-10-21
PL3580571T3 (pl) 2023-07-31
IL268377B1 (en) 2023-11-01
AU2018217872A1 (en) 2019-09-12
CN110446929A (zh) 2019-11-12
EP3580571C0 (en) 2023-06-07
JP7108638B2 (ja) 2022-07-28
WO2018146129A1 (en) 2018-08-16
IL268377B2 (en) 2024-03-01
US20190361035A1 (en) 2019-11-28
ES2948232T3 (es) 2023-09-06
IL268377A (en) 2019-09-26
US11402389B2 (en) 2022-08-02
BR112019016182A2 (pt) 2020-04-07
EP3580571A1 (en) 2019-12-18
EP3580571B1 (en) 2023-06-07
BR112019016182A8 (pt) 2022-10-18
KR20190120232A (ko) 2019-10-23
RU2019126238A (ru) 2021-03-09
CA3052720A1 (en) 2018-08-16
US20230160910A1 (en) 2023-05-25

Similar Documents

Publication Publication Date Title
BR122021024397A2 (ru)
BR122021023687A2 (ru)
BR122022003520A2 (ru)
BR122021000189A2 (ru)
BR122022025811B8 (ru)
BR112019008823A2 (ru)
BR112020006084A8 (ru)
BR122021014832A2 (ru)
RU2019126238A3 (ru)
BR202018014992U2 (ru)
BR112020008820A2 (ru)
BR202017025154U2 (ru)
BR102017023327A2 (ru)
BR202017021228U2 (ru)
BR202017020981U2 (ru)
BR202017017068U2 (ru)
BR202017016984U2 (ru)
BR202017016924U2 (ru)
BR102017015495A2 (ru)
BR102017015250A2 (ru)
BR102017014430A2 (ru)
BR202017012548U2 (ru)
BR202017011220U2 (ru)
BR202017010814U2 (ru)
BR202017010373U2 (ru)